Arkolith/Insider Trading/PTHS/Form 4

Friedberg Ezra M

DirectorPelthos Therapeutics Inc. (PTHS) · full profile →Form 4 · filed Nov 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$280K
Net Open-Market Flow
-$280K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2025Sell(S)6K$28.00$168K34K
Nov 25, 2025Sell(S)2K$28.01$56K30K
Nov 25, 2025Sell(S)1$28.50$2932K
Nov 25, 2025Sell(S)2K$28.14$56K32K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-25-001831) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML